04.11.2021 • News

Usalco and G2O Technologies Merge

Usalco, a portfolio company of investment firm H.I.G. Capital, has completed a merger with G2O Technologies, owned by private equity group Arsenal Capital Partners. The merger creates one of North America’s leading water treatment chemical companies with 27 sites across the Americas.

The combined entity will continue to be known as Usalco and Ken Gayer, CEO of Usalco prior to the merger, will lead the new company. It will offer a range of products, including aluminum and iron salts, organic polymers and specialty blended formulations.

“Our complementary products and broader geographic reach will allow us to offer an expanded set of solutions that help improve our customers’ water treatment processes and protect our water resources,” said Gayer.

Including G2O, Usalco has completed four strategic transactions since H.I.G. recapitalized the business in June 2020. The other transactions were AlChem Specialties and CalChem Specialties in December 2020 and Altivia’s water treatment business in September of this year.

G2O Technologies, headquartered in Phillipsburg, New Jersey, was formed in April 2020 through a merger of Gulbrandsen and GEO Specialty Chemicals water treatment divisions.

Author: Elaine Burridge, Freelance Journalist

USALCO, a portfolio company of investment firm H.I.G. Capital, has merged with...
USALCO, a portfolio company of investment firm H.I.G. Capital, has merged with G2O Technologies, owned by private equity group Arsenal Capital Partners. The merger creates one of North America’s leading water treatment chemical firms with 27 sites across the Americas. Photo by J K on Unsplash

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.